McKinsey's agreement to pay $650 million is a significant step in addressing its role in advising Purdue Pharma on boosting OxyContin sales during the opioid crisis.
The firm's statement expressed deep regret about their work for Purdue Pharma, admitting a failure to recognize the societal harm caused by opioids.
Martin Elling, a former McKinsey partner, faces charges for obstruction of justice for destroying evidence regarding the firm's dealings with Purdue.
The deferred prosecution agreement requires McKinsey to enhance compliance practices and submit to oversight, reflecting the serious nature of the opioid epidemic.
Collection
[
|
...
]